Retatrutide Study in Obese Type 2 Diabetics Concludes | Retatrutide News

A clinical trial on retatrutide for obese type 2 diabetics has been completed. The study lasted 89 weeks and included participants with obstructive slee...
Clinical Trials · October 28, 2026